AMPH FY 2023 Earnings — Amphastar Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

AMPHAmphastar Pharmaceuticals, Inc.

$894M

FY 2023 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$644M+29.1% YoY

Gross Profit

$351M54.5% margin

Operating Income

$197M30.6% margin

Net Income

$138M21.3% margin

EPS (Diluted)

$2.60

Cash Flow

Operating Cash Flow

$184M

Free Cash Flow

$145M

Stock-Based Comp.

$20M

Balance Sheet

Total Assets

$1.5B

Total Liabilities

$873M

Stockholders' Equity

$639M

Cash & Equivalents

$144M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$644M	$499M	+29.1%
Gross Profit	$351M	$249M	+41.1%
Operating Income	$197M	$107M	+83.2%
Net Income	$138M	$91M	+50.5%